AZN
Price:
$83.05
Market Cap:
$257.50B
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/On...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1993-05-12
Stock Exchange
NASDAQ
Ticker
AZN
According to AstraZeneca PLC’s latest financial reports and current stock price. The company's current Enterprise Value is 284.12B. This represents a change of 17.38% compared to the average of 242.05B of the last 4 quarters.
The mean historical Enterprise Value of AstraZeneca PLC over the last ten years is 142.38B. The current 284.12B Enterprise Value has changed 19.85% with respect to the historical average. Over the past ten years (40 quarters), AZN's Enterprise Value was at its highest in in the June 2024 quarter at 268.23B. The Enterprise Value was at its lowest in in the December 2016 quarter at 80.91B.
Average
142.38B
Median
126.56B
Minimum
80.91B
Maximum
232.97B
Discovering the peaks and valleys of AstraZeneca PLC Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 31.96%
Maximum Annual Enterprise Value = 232.97B
Minimum Annual Increase = -14.51%
Minimum Annual Enterprise Value = 80.91B
Year | Enterprise Value | Change |
---|---|---|
2023 | 231.43B | -0.66% |
2022 | 232.97B | 22.85% |
2021 | 189.65B | 31.96% |
2020 | 143.72B | 0.79% |
2019 | 142.59B | 29.02% |
2018 | 110.52B | 6.21% |
2017 | 104.07B | 28.62% |
2016 | 80.91B | -14.51% |
2015 | 94.64B | 1.43% |
2014 | 93.30B | 23.58% |
The current Enterprise Value of AstraZeneca PLC (AZN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
218.02B
5-year avg
188.07B
10-year avg
142.38B
AstraZeneca PLC’s Enterprise Value is greater than Novartis AG (249.31B), greater than GSK plc (81.81B), greater than Roche Holding AG (251.71B), greater than Bristol-Myers Squibb Company (146.44B), greater than Sanofi (147.45B), less than Merck & Co., Inc. (325.14B), greater than Gilead Sciences, Inc. (118.58B), less than Johnson & Johnson (412.32B), less than AbbVie Inc. (399.11B), less than Eli Lilly and Company (883.63B), greater than Pfizer Inc. (230.24B), greater than Amgen Inc. (225.59B),
Company | Enterprise Value | Market cap |
---|---|---|
249.31B | $228.22B | |
81.81B | $89.06B | |
251.71B | $263.51B | |
146.44B | $98.73B | |
147.45B | $144.70B | |
325.14B | $298.70B | |
118.58B | $98.01B | |
412.32B | $395.70B | |
399.11B | $341.61B | |
883.63B | $857.96B | |
230.24B | $161.84B | |
225.59B | $172.25B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AstraZeneca PLC using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AstraZeneca PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is AstraZeneca PLC's Enterprise Value?
What is the highest Enterprise Value for AstraZeneca PLC (AZN)?
What is the 3-year average Enterprise Value for AstraZeneca PLC (AZN)?
What is the 5-year average Enterprise Value for AstraZeneca PLC (AZN)?
How does the current Enterprise Value for AstraZeneca PLC (AZN) compare to its historical average?